REZOLUTE, INC. Shares Issued, Shares, Share-based Payment Arrangement, Forfeited
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- REZOLUTE, INC. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2026-06-30 was 115.44K shares, a 85.33% increase year-over-year.
- REZOLUTE, INC. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2026-03-31 was 24.39K shares, a 85.67% decline year-over-year.
- REZOLUTE, INC. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2025-12-31 was 1.64M shares.
- REZOLUTE, INC. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2025-09-30 was 115.00K shares, a 63.84% decline year-over-year.
- REZOLUTE, INC. shares issued, shares, share-based payment arrangement, forfeited for fiscal 2026 was 1.89M shares, a 243.88% increase from fiscal 2025.
- REZOLUTE, INC. shares issued, shares, share-based payment arrangement, forfeited for fiscal 2025 was 550.44K shares, a 81.24% increase from fiscal 2024.
- REZOLUTE, INC. shares issued, shares, share-based payment arrangement, forfeited for fiscal 2024 was 303.71K shares, a 21.11% decline from fiscal 2023.
- REZOLUTE, INC. shares issued, shares, share-based payment arrangement, forfeited for fiscal 2023 was 385.00K shares, a 420.27% increase from fiscal 2022.
| Period end | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 3 month | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 12 month |
|---|---|---|
| 2026-06-30 | 115.44K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-24 | 1.89M shares 10-K · filed 2026-09-24 |
| 2026-03-31 | 24.39K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-12 | 1.84M shares derived: sum of 4 quarters · filed 2026-09-24 |
| 2025-12-31 | 1.64M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | 1.99M shares derived: sum of 4 quarters · filed 2026-09-24 |
| 2025-09-30 | 115.00K shares 10-Q · filed 2025-11-06 | 347.44K shares derived: sum of 4 quarters · filed 2026-09-24 |
| 2025-06-30 | 62.29K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-24 | 550.44K shares 10-K · filed 2026-09-24 |
| 2025-03-31 | 170.15K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13 | 520.86K shares derived: sum of 4 quarters · filed 2025-09-17 |
| 2024-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-12 | 456.71K shares derived: sum of 4 quarters · filed 2025-09-17 |
| 2024-09-30 | 318.00K shares 10-Q · filed 2024-11-07 | 597.71K shares derived: sum of 4 quarters · filed 2025-09-17 |
| 2024-06-30 | 32.71K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-17 | 303.71K shares 10-K · filed 2025-09-17 |
| 2024-03-31 | 106.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | 377.00K shares derived: sum of 4 quarters · filed 2024-09-19 |
| 2023-12-31 | 141.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13 | 256.00K shares derived: sum of 4 quarters · filed 2024-09-19 |
| 2023-09-30 | 24.00K shares 10-Q · filed 2023-11-13 | 301.00K shares derived: sum of 4 quarters · filed 2024-09-19 |
| 2023-06-30 | 106.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-19 | 385.00K shares 10-K · filed 2024-09-19 |
| 2023-03-31 | -15.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | 295.00K shares derived: sum of 4 quarters · filed 2023-09-14 |
| 2022-12-31 | 186.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-10 | 281.00K shares derived: sum of 4 quarters · filed 2023-09-14 |
| 2022-09-30 | 108.00K shares 10-Q · filed 2022-11-09 | 151.00K shares derived: sum of 4 quarters · filed 2023-09-14 |
| 2022-06-30 | 16.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-14 | 74.00K shares 10-K · filed 2023-09-14 |
| 2022-03-31 | -29.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-12 | |
| 2021-12-31 | 56.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-09 | |
| 2021-09-30 | 31.00K shares 10-Q · filed 2021-11-12 | |
| 2019-12-31 | 399.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-12 | -43.97K shares derived: sum of 4 quarters · filed 2020-02-12 |
| 2019-09-30 | 1.39M shares 10-Q · filed 2019-11-14 | -306.09K shares derived: sum of 4 quarters · filed 2019-11-14 |
| 2019-06-30 | -3.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-10 | 6.67K shares 10-K · filed 2019-09-10 |
| 2019-03-31 | 1.83M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-10 | 3.19M shares derived: sum of 4 quarters · filed 2019-09-10 |
| 2018-12-31 | 136.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-14 | 1.38M shares derived: sum of 4 quarters · filed 2019-09-10 |
| 2018-09-30 | 1.70M shares 10-Q · filed 2018-12-14 | 1.68M shares derived: sum of 4 quarters · filed 2019-09-10 |
| 2018-06-30 | -484.29K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-10 | 1.88K shares 10-K · filed 2019-09-10 |
| 2018-03-31 | 29.17K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-15 | |
| 2017-12-31 | 432.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | |
| 2017-09-30 | 25.00K shares 10-Q · filed 2017-11-14 | |
| 2017-06-30 | 125.00K shares 10-K · filed 2018-10-15 | |
| 2016-06-30 | 40.00K shares 10-K · filed 2017-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |